The risk of breast cancer in first degree relatives of patients with breast cancer can be derived from family history and is dependent upon the age at diagnosis in the index patient. For the relatives of index patients older than 55, the relative risk is 1-57, if less than 55 the relative risk is 2-29, and 3 85 if less than 45 (95% confidence limits 0-83 to 2-68, 1P18 to 4-01, and 1-67 to 3 85, respectively Patients and pedigrees Two hundred and fifty-four consecutive pedigrees were ascertained through women diagnosed with histologically proven breast cancer attending follow up breast clinics at the Royal Free Hospital and University College Hospital. The first 204 were unselected cases but the last 50 were selected for premenopausal onset. No pedigree was selected for family history. Pedigrees were all taken by a single pedigree worker. One pedigree was excluded from analysis because of insufficient information on family members.
Cancer of the breast is a common malignancy in women, and while environmental and reproductive experience plays a significant role in its aetiology, family history has long been recognised as an important risk factor. ' Patients and pedigrees Two hundred and fifty-four consecutive pedigrees were ascertained through women diagnosed with histologically proven breast cancer attending follow up breast clinics at the Royal Free Hospital and University College Hospital. The first 204 were unselected cases but the last 50 were selected for premenopausal onset. No pedigree was selected for family history. Pedigrees were all taken by a single pedigree worker. One pedigree was excluded from analysis because of insufficient information on family members.
Of the 166 deaths in first degree relatives from all types of cancer, 130 (78%) were verified by death certificates or hospital records, and in 26 first degree relatives alive with cancer the diagnosis was verified from hospital records in 14 (56%). Data on living relatives with cancer were only recorded for the purpose of syndrome identification and not for estimation of risks.
Index patients were divided into those who developed breast cancer before 45, 50, and 55, and those who developed it after 55. Of the 20 patients who developed breast cancer between the ages of 50 and 54, 11 were reported to be premenopausal. 
Calculation of risks

Results
These index patients provided a total of 32 085 years at risk in female first degree relatives and 28 475 in males.
The observed number of deaths from breast cancer and relative risks are shown in the table.
Overall the relative risk of breast cancer in first degree relatives of all index patients is 1 85 but is most marked for those relatives of index patients less than 45 years old. Furthermore, for relatives of patients diagnosed before 55, a 2-84-fold increase in risk is seen before the age of 55. There were no breast cancer deaths in sisters or daughters of patients diagnosed with breast cancer below the age of 55. It should be noted that the number of years at risk for sisters and daughters of patients diagnosed before 55 is only 5765 and 1070, respectively, with a correspondingly low expected number of deaths from breast cancer of 1-56 and 0-06.
Overall an increased risk for sisters was seen, but this was not significant (relative risk= 1-31, 95% confidence limits 0 52 to 2 70). Daughters showed a 5 88-fold increase in risk overall, which was statistically significant (p<0 05, 95% confidence limits 0 71 to 21 -22) , but was dependent on only two observed deaths in daughters under 55.
Observed numbers of deaths from all causes are not different from the expected for either males or females. The observed numbers of deaths and relative risks for all female and male first degree relatives for all deaths, all cancers, cancers of the ovary, uterus, colorectum, lung, and prostate were investigated. There Age of first degree relative (years) Figure 2 Total lifetime probability of developing breast cancer with increasing age in relation to age of diagnosis (A) in index patients (IPS).
cancer with increasing age in relatives of patients diagnosed at different ages, assuming that the age of onset for those genetically susceptible within families is independent of the age of onset in the phenocopies. Fig 3  shows Clearly there is an opportunity to identify women at risk through their family history in whom screening may be of benefit, starting at an earlier age than currently being offered through the national screening programme.
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